{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T11:57:42Z","timestamp":1781351862871,"version":"3.54.1"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T00:00:00Z","timestamp":1771200000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005795","name":"Chang Gung Medical Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005795","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Global Antimicrobial Resistance"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.jgar.2026.02.006","type":"journal-article","created":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T16:41:52Z","timestamp":1771605712000},"page":"65-72","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Evolution of late hepatitis C relapse among patients with previous sustained virological responses: An 18-year prospective study"],"prefix":"10.1016","volume":"48","author":[{"given":"Wei-Ting","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Jyun","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong-Nan","family":"Chien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4902-4401","authenticated-orcid":false,"given":"Ming-Ling","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10407","key":"10.1016\/j.jgar.2026.02.006_bib0001","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/S0140-6736(23)01320-X","article-title":"Hepatitis C","volume":"402","author":"Martinello","year":"2023","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.jgar.2026.02.006_bib0002","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1080\/21505594.2020.1838742","article-title":"Altering retinol binding protein 4 levels in hepatitis C: inflammation and steatosis matter","volume":"11","author":"Chang","year":"2020","journal-title":"Virulence"},{"issue":"4","key":"10.1016\/j.jgar.2026.02.006_bib0003","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.3748\/wjg.v22.i4.1461","article-title":"Metabolic alterations and hepatitis C: from bench to bedside","volume":"22","author":"Chang","year":"2016","journal-title":"World J Gastroenterol"},{"issue":"3","key":"10.1016\/j.jgar.2026.02.006_bib0004","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.cmi.2019.06.018","article-title":"Rheumatoid factor and immunoglobulin M mark hepatitis C-associated mixed cryoglobulinaemia: an 8-year prospective study","volume":"26","author":"Cheng","year":"2020","journal-title":"Clin Microbiol Infect"},{"issue":"3","key":"10.1016\/j.jgar.2026.02.006_bib0005","doi-asserted-by":"crossref","first-page":"464","DOI":"10.3390\/v13030464","article-title":"Genetic association of hepatitis C-related mixed cryoglobulinemia: a 10-year prospective study of Asians treated with antivirals","volume":"13","author":"Chang","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.jgar.2026.02.006_bib0006","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.823160","article-title":"Evolution of cryoglobulinemia in direct-acting antiviral-treated asian Hepatitis C patients with sustained virological responses: a 4-year prospective cohort study","volume":"13","author":"Chang","year":"2022","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.jgar.2026.02.006_bib0007","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.jiph.2024.01.010","article-title":"Long-term renal function alterations in hepatitis C patients with SVRs: impacts of therapies and mixed cryoglobulinemia","volume":"17","author":"Chang","year":"2024","journal-title":"J Infect Public Health"},{"issue":"1","key":"10.1016\/j.jgar.2026.02.006_bib0008","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2025.2470128","article-title":"Mixed cryoglobulinemia decelerates hepatocellular carcinoma development in hepatitis C patients with SVR by downregulating regulatory B cells: a 12-year prospective cohort study","volume":"14","author":"Chang","year":"2025","journal-title":"Oncoimmunology"},{"issue":"4","key":"10.1016\/j.jgar.2026.02.006_bib0009","doi-asserted-by":"crossref","first-page":"817","DOI":"10.3390\/jcm10040817","article-title":"Impact of interferon-based therapy on hepatitis C-associated rheumatic diseases: a nationwide population-based cohort study","volume":"10","author":"Cheng","year":"2021","journal-title":"J Clin Med"},{"issue":"1","key":"10.1016\/j.jgar.2026.02.006_bib0010","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1080\/21505594.2020.1870080","article-title":"Accelerated cardiovascular risk after viral clearance in hepatitis C patients with the NAMPT-rs61330082 TT genotype: an 8-year prospective cohort study","volume":"12","author":"Chang","year":"2021","journal-title":"Virulence"},{"key":"10.1016\/j.jgar.2026.02.006_bib0011","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.trsl.2022.02.009","article-title":"Association between breast cancer and hepatitis C: a joint study of hospitalized patients and nationwide cohorts","volume":"245","author":"Cheng","year":"2022","journal-title":"Transl Res"},{"issue":"11","key":"10.1016\/j.jgar.2026.02.006_bib0012","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.3390\/jcm10112395","article-title":"Association between Hepatitis C Virus infection and esophageal cancer: an Asian nationwide population-based cohort study","volume":"10","author":"Chu","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.jgar.2026.02.006_bib0013","doi-asserted-by":"crossref","DOI":"10.1177\/1756284819855732","article-title":"The irreversible HCV-associated risk of gastric cancer following interferon-based therapy: a joint study of hospital-based cases and nationwide population-based cohorts","volume":"12","author":"Chen","year":"2019","journal-title":"Therap Adv Gastroenterol"},{"issue":"7","key":"10.1016\/j.jgar.2026.02.006_bib0014","first-page":"3080","article-title":"Hepatitis C accelerates extrahepatic cholangiocarcinoma risk: a joint study of hospital-based cases and nationwide population-based cohorts in a viral hepatitis-endemic area","volume":"13","author":"Huang","year":"2023","journal-title":"Am J Cancer Res"},{"issue":"1","key":"10.1016\/j.jgar.2026.02.006_bib0015","first-page":"39","article-title":"Different metabolic associations of hepatitis C with colon and rectal cancers: a 9-year nationwide population-based cohort study","volume":"24","author":"Chen","year":"2025","journal-title":"Clin Colorectal Cancer"},{"issue":"9","key":"10.1016\/j.jgar.2026.02.006_bib0016","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1086\/630205","article-title":"Rate and timing of hepatitis C virus relapse after a successful course of pegylated interferon plus ribavirin in HIV-infected and HIV-uninfected patients","volume":"49","author":"Medrano","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.jgar.2026.02.006_bib0017","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1093\/cid\/civ948","article-title":"Risk of late relapse or reinfection with Hepatitis C virus after achieving a sustained virological response: a systematic review and meta-analysis","volume":"62","author":"Simmons","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jgar.2026.02.006_bib0018","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/S0168-8278(99)80129-9","article-title":"Long-term follow-up of chronic hepatitis C patients with sustained virological response to alpha-interferon","volume":"30","author":"Reichard","year":"1999","journal-title":"J Hepatol"},{"key":"10.1016\/j.jgar.2026.02.006_bib0019","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.ebiom.2019.07.043","article-title":"Detection of residual HCV-RNA in patients who have achieved sustained virological response is associated with persistent histological abnormality","volume":"46","author":"Wang","year":"2019","journal-title":"EBioMedicine"},{"issue":"7","key":"10.1016\/j.jgar.2026.02.006_bib0020","doi-asserted-by":"crossref","first-page":"723","DOI":"10.3851\/IMP2753","article-title":"Very late HCV relapse following triple therapy for hepatitis C","volume":"19","author":"Barreiro","year":"2014","journal-title":"Antivir Ther"},{"key":"10.1016\/j.jgar.2026.02.006_bib0021","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1111\/jvh.12967","article-title":"Late relapse of hepatitis C virus in patients with sustained virological response after daclatasvir and asunaprevir therapy","volume":"25","author":"Hayashi","year":"2018","journal-title":"J Viral Hepat"},{"issue":"11","key":"10.1016\/j.jgar.2026.02.006_bib0022","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1016\/j.cgh.2020.06.061","article-title":"Spontaneous clearance after relapse following direct-acting antiviral treatment for chronic HCV infection","volume":"19","author":"Kuriry","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"8","key":"10.1016\/j.jgar.2026.02.006_bib0023","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.3851\/IMP2659","article-title":"Very late relapse after discontinuation of antiviral therapy for chronic hepatitis C","volume":"18","author":"Soriano","year":"2013","journal-title":"Antivir Ther"},{"key":"10.1016\/j.jgar.2026.02.006_bib0024","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.02922-24","article-title":"HCV ab titer and ALT level indicate occult hepatitis C virus infection in treatment-naive HCV Ab-positive and HCV Ab-negative patients: a 3-year prospective cohort study","author":"Chang","year":"2025","journal-title":"Microbiol Spectr"},{"issue":"3","key":"10.1016\/j.jgar.2026.02.006_bib0025","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1053\/j.gastro.2016.11.002","article-title":"Detection of occult Hepatitis C virus infection in patients who achieved a sustained virologic response to direct-acting antiviral agents for recurrent infection after liver transplantation","volume":"152","author":"Elmasry","year":"2017","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.jgar.2026.02.006_bib0026","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1111\/j.1365-2516.2008.01773.x","article-title":"Evidence of occult HCV genotypes in haemophilic individuals with unapparent HCV mixed infections","volume":"14","author":"Parodi","year":"2008","journal-title":"Haemophilia"},{"issue":"18","key":"10.1016\/j.jgar.2026.02.006_bib0027","doi-asserted-by":"crossref","first-page":"e3546","DOI":"10.1097\/MD.0000000000003546","article-title":"Sexual dimorphic metabolic alterations in Hepatitis C virus-infected patients: a community-based study in a Hepatitis B\/Hepatitis C virus hyperendemic area","volume":"95","author":"Hu","year":"2016","journal-title":"Medicine"},{"issue":"2","key":"10.1016\/j.jgar.2026.02.006_bib0028","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1111\/cas.16042","article-title":"Association of liver fibrosis with extrahepatic cancer in steatotic liver disease patients with PNPLA3 I148M GG genotype","volume":"115","author":"Tai","year":"2024","journal-title":"Cancer Sci"},{"issue":"7","key":"10.1016\/j.jgar.2026.02.006_bib0029","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.1111\/dom.15622","article-title":"Factors associated with treatment responses to pioglitazone in patients with steatotic liver disease: a 3-year prospective cohort study","volume":"26","author":"Chang","year":"2024","journal-title":"Diabetes Obes Metab"},{"issue":"1","key":"10.1016\/j.jgar.2026.02.006_bib0030","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/s12072-024-10761-8","article-title":"Rheumatoid factor levels indicate cryoglobulinemia severity in hepatitis B e antigen-negative hepatitis B virus carriers: a 7-year prospective cohort study","volume":"19","author":"Wu","year":"2025","journal-title":"Hepatol Int"},{"key":"10.1016\/j.jgar.2026.02.006_bib0031","doi-asserted-by":"crossref","DOI":"10.1016\/j.meegid.2019.104144","article-title":"Occult hepatitis C virus infection in hemophilia patients and its correlation with interferon lambda 3 and 4 polymorphisms","volume":"79","author":"Nafari","year":"2020","journal-title":"Infect Genet Evol"},{"issue":"1","key":"10.1016\/j.jgar.2026.02.006_bib0032","doi-asserted-by":"crossref","first-page":"7577","DOI":"10.1038\/s41598-019-44081-x","article-title":"The extrahepatic events of Asian patients with primary biliary cholangitis: a 30-year cohort study","volume":"9","author":"Lin","year":"2019","journal-title":"Sci Rep"},{"issue":"9","key":"10.1016\/j.jgar.2026.02.006_bib0033","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1016\/j.cgh.2020.01.018","article-title":"Hepatitis flares are associated with better outcomes than No flare in patients with decompensated cirrhosis and chronic Hepatitis B virus infection","volume":"18","author":"Chang","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"12","key":"10.1016\/j.jgar.2026.02.006_bib0034","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1111\/jgh.16736","article-title":"Distinct characteristics of various autoimmune liver diseases: a 22-year hospital-based study in Taiwan","volume":"39","author":"Chang","year":"2024","journal-title":"J Gastroenterol Hepatol"},{"issue":"9","key":"10.1016\/j.jgar.2026.02.006_bib0035","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/nrgastro.2013.107","article-title":"Epidemiology and natural history of HCV infection","volume":"10","author":"Hajarizadeh","year":"2013","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.jgar.2026.02.006_bib0036","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1007\/s15010-024-02433-4","article-title":"Real-life data of hepatitis C treatment with direct acting antiviral therapy in persons injecting drugs or on opioid substitution therapy","volume":"53","author":"Pfaeffle","year":"2025","journal-title":"Infection"},{"issue":"3","key":"10.1016\/j.jgar.2026.02.006_bib0037","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0229239","article-title":"Directly observed therapy for HCV with glecaprevir\/pibrentasvir alongside opioid substitution in people who inject drugs-first real world data from Austria","volume":"15","author":"Schmidbauer","year":"2020","journal-title":"PLoS ONE"},{"issue":"1","key":"10.1016\/j.jgar.2026.02.006_bib0038","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s43141-023-00544-3","article-title":"Recognition of 7 genes signature (Cirrhosis Risk Score) in the diagnosed non-responders to DAAs therapy by intra-PBMCs nested HCV RNA PCR","volume":"21","author":"Galal","year":"2023","journal-title":"J Genet Eng Biotechnol"},{"issue":"4","key":"10.1016\/j.jgar.2026.02.006_bib0039","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1089\/088922204323048096","article-title":"Hepatitis C virus (HCV) relapses after anti-HCV therapy are more frequent in HIV-infected patients","volume":"20","author":"Soriano","year":"2004","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"5","key":"10.1016\/j.jgar.2026.02.006_bib0040","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1007\/s15010-018-1158-9","article-title":"HCV very late relapse following an atypical viral kinetics in a HIV patient treated for hepatitis C with direct-acting antivirals","volume":"46","author":"Guardigni","year":"2018","journal-title":"Infection"},{"issue":"7262","key":"10.1016\/j.jgar.2026.02.006_bib0041","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nature08309","article-title":"Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance","volume":"461","author":"Ge","year":"2009","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.jgar.2026.02.006_bib0042","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s00535-018-1520-9","article-title":"Real-world efficacy of glecaprevir plus pibrentasvir for chronic hepatitis C patient with previous direct-acting antiviral therapy failures","volume":"54","author":"Osawa","year":"2019","journal-title":"J Gastroenterol"},{"issue":"11","key":"10.1016\/j.jgar.2026.02.006_bib0043","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e21194","article-title":"HCV treatment outcome depends on SNPs of IFNL3-gene polymorphisms (rs12979860) and cirrhotic changes in liver parenchyma","volume":"9","author":"Abd Alla","year":"2023","journal-title":"Heliyon"},{"issue":"1","key":"10.1016\/j.jgar.2026.02.006_bib0044","doi-asserted-by":"crossref","DOI":"10.1111\/eci.13189","article-title":"Impact of mixed cryoglobulinemia on patients with spontaneous hepatitis C virus clearance: a 13-year prospective cohort study","volume":"50","author":"Lee","year":"2020","journal-title":"Eur J Clin Invest"},{"issue":"24","key":"10.1016\/j.jgar.2026.02.006_bib0045","doi-asserted-by":"crossref","first-page":"5874","DOI":"10.3390\/jcm10245874","article-title":"Occult infection with Hepatitis C Virus: looking for clear-cut boundaries and methodological consensus","volume":"10","author":"Wr\u00f3blewska","year":"2021","journal-title":"J Clin Med"},{"issue":"1","key":"10.1016\/j.jgar.2026.02.006_bib0046","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/hep.21283","article-title":"Extrahepatic replication of HCV: insights into clinical manifestations and biological consequences","volume":"44","author":"Blackard","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.jgar.2026.02.006_bib0047","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/579147","article-title":"A new twist to a chronic HCV infection: occult Hepatitis C","volume":"2015","author":"Attar","year":"2015","journal-title":"Gastroenterol Res Pract"},{"issue":"4","key":"10.1016\/j.jgar.2026.02.006_bib0048","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/jmv.1890430411","article-title":"Hepatitis C virus-polymerase chain reaction of routinely processed liver biopsies","volume":"43","author":"el-Batanony","year":"1994","journal-title":"J Med Virol"},{"issue":"10","key":"10.1016\/j.jgar.2026.02.006_bib0049","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1111\/j.1478-3231.2011.02613.x","article-title":"Long-term virological follow up of patients with occult hepatitis C virus infection","volume":"31","author":"Castillo","year":"2011","journal-title":"Liver Int"},{"issue":"2","key":"10.1016\/j.jgar.2026.02.006_bib0050","doi-asserted-by":"crossref","first-page":"125","DOI":"10.5114\/ceh.2022.115116","article-title":"Occult HCV infection in liver transplanted patients: frequency and consequences","volume":"8","author":"Saad","year":"2022","journal-title":"Clin Exp Hepatol"},{"issue":"1","key":"10.1016\/j.jgar.2026.02.006_bib0051","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1093\/cid\/ciaf008","article-title":"Analysis of repeat Hepatitis C viremia after sustained virologic response in a large cohort of US veterans","volume":"81","author":"Matelski","year":"2025","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.jgar.2026.02.006_bib0052","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.jceh.2021.11.004","article-title":"Value of liver function tests in cirrhosis","volume":"12","author":"Sharma","year":"2022","journal-title":"J Clin Exp Hepatol"},{"issue":"8","key":"10.1016\/j.jgar.2026.02.006_bib0053","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0104783","article-title":"Distinct patterns of the lipid alterations between genotype 1 and 2 chronic hepatitis C patients after viral clearance","volume":"9","author":"Chang","year":"2014","journal-title":"PLoS ONE"}],"container-title":["Journal of Global Antimicrobial Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716526000238?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716526000238?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T11:28:29Z","timestamp":1781350109000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213716526000238"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":53,"alternative-id":["S2213716526000238"],"URL":"https:\/\/doi.org\/10.1016\/j.jgar.2026.02.006","relation":{},"ISSN":["2213-7165"],"issn-type":[{"value":"2213-7165","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evolution of late hepatitis C relapse among patients with previous sustained virological responses: An 18-year prospective study","name":"articletitle","label":"Article Title"},{"value":"Journal of Global Antimicrobial Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgar.2026.02.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd on behalf of International Society for Antimicrobial Chemotherapy.","name":"copyright","label":"Copyright"}]}}